Brief: Fulgent Genetics Inc Says Under Terms Of Agreement, Co Acquired Fulgent Pharma For A Total Purchase Price Of About $100 Mln
07/11/2022 23:11
Nov 7 (Reuters) - Fulgent Genetics Inc FLGT.O :
* FULGENT GENETICS INC- UNDER TERMS OF AGREEMENT, FULGENT
GENETICS
ACQUIRED FULGENT PHARMA FOR A TOTAL PURCHASE PRICE OF
APPROXIMATELY $100 MILLION
Source text for Eikon: ID:nBw512z2Na
Further company coverage: FLGT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fulgent Genetics
See all newsU.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
Fulgent Genetics Inc reports results for the quarter ended June 30 - Earnings Summary
Fulgent Genetics Q2 revenue rises 20% sequentially, sees billing system transition delay
Brief: Fulgent Genetics Q2 Revenue USD 85.389 Million
Fulgent Genetics Inc expected to post a loss of 46 cents a share - Earnings Preview